USA Top Companies List by Market Cap in January 2024

USA Top Companies List by Market Cap as of Jan-05-2024. Biggest USA Companies List by Market Cap in 2024. USA Largest Companies in 2024.

USA Top 500 Companies by Market Cap in 2024

Total Market Cap and Net worth of USA Top 500 Companies which are listed on stock exchanges and also unlisted companies is 44.09 Trillion USD as of Jan-05-2024. To compute market cap of USA Top 500 companies only considered USA headquartered companies.

USA key business leaders like Steve Jobs, Bill Gates, Elon Musk, Jeff Bezos, Larry Page, Sergey Brin, Mark Zuckerberg, Warren Buffet, Larry Ellison, Tim Cook, Jamie Dimon are couple of strong business leaders who laid foundation stones for USA economy growth and made USA World number 1 by GDP.

Total Market Cap and Net worth of USA Top 1,000 Companies which are listed on stock exchanges and also unlisted companies is 48.61 Trillion USD as of Jan-05-2024.

USA Top 500 Companies by Market Cap in 2024, USA Largest 500 Companies List in January 2024, USA Biggest 500 Companies by Market Cap in January 2024.

Mayville Engineering Company

Rank as per Search Criteria: 3821

World Rank (Jan-2024): 16,428

Market Cap (Jan-05-2024): 0.27 Billion USD

World Rank (Jul-30-2023): 16,924

Market Cap (Jul-30-2023): 0.25 Billion USD

World Rank (Jan-07-2022): 16,717

Market Cap (Jan-07-2022): 0.30 Billion USD

Headquarters Country: USA

Business Sector: Engineering Products, Engineering Services, Metal Fabrication Products

Annual Revenue in USD: 358 Million USD

Annual Net Income in USD: -7 Million USD

Annual Results for Period Ending: Dec-2020 ending year

Stock Price: Yahoo @ NYSE

Company Website: MAYVILLE ENGINEERING COMPANY

BayCom Corp.

Rank as per Search Criteria: 3822

World Rank (Jan-2024): 16,436

Market Cap (Jan-05-2024): 0.27 Billion USD

World Rank (Jul-30-2023): 16,948

Market Cap (Jul-30-2023): 0.25 Billion USD

World Rank (Jan-07-2022): 18,866

Market Cap (Jan-07-2022): 0.21 Billion USD

Headquarters Country: USA

Business Sector: Financial Services, Banking Services

Annual Revenue in USD: 87 Million USD

Annual Net Income in USD: 14 Million USD

Annual Results for Period Ending: Dec-2020 ending year

Stock Price: Yahoo @ Nasdaq

Company Website: BAYCOM CORP

Accuray

Rank as per Search Criteria: 3823

World Rank (Jan-2024): 16,437

Market Cap (Jan-05-2024): 0.27 Billion USD

World Rank (Jul-30-2023): 14,105

Market Cap (Jul-30-2023): 0.40 Billion USD

World Rank (Jan-07-2022): 15,093

Market Cap (Jan-07-2022): 0.39 Billion USD

Headquarters Country: USA

Business Sector: Healthcare, Medical Equipment / Instruments, HealthCare Products

Annual Revenue in USD: 383 Million USD

Annual Net Income in USD: 4 Million USD

Annual Results for Period Ending: Jun-2020 ending year

Employee Count: 995

Employee Count as of Date: As on 2021

Company Profile:

Accuray is Develops, Manufactures and Sells Radiotherapy Systems company for alternative cancer treatments. The company annual revenue is 754.6 million USD and 947 employees as on 2020. The headquarters is in USA.

Stock Price: Yahoo @ Frankfurt

Company Website: ACCURAY

NL Industries Inc.

Rank as per Search Criteria: 3824

World Rank (Jan-2024): 16,443

Market Cap (Jan-05-2024): 0.27 Billion USD

World Rank (Jul-30-2023): 16,171

Market Cap (Jul-30-2023): 0.28 Billion USD

World Rank (Jan-07-2022): 15,596

Market Cap (Jan-07-2022): 0.36 Billion USD

Headquarters Country: USA

Business Sector: Chemicals

Annual Revenue in USD: 115 Million USD

Annual Net Income in USD: 15 Million USD

Annual Results for Period Ending: Dec-2020 ending year

Employee Count: 2,818

Employee Count as of Date: As on December-2021

Stock Price: Yahoo @ NYSE

Company Website: NL INDUSTRIES

Inozyme Pharma Inc.

Rank as per Search Criteria: 3825

World Rank (Jan-2024): 16,447

Market Cap (Jan-05-2024): 0.27 Billion USD

World Rank (Jul-30-2023): 17,663

Market Cap (Jul-30-2023): 0.22 Billion USD

World Rank (Jan-07-2022): 20,454

Market Cap (Jan-07-2022): 0.15 Billion USD

Headquarters Country: USA

Business Sector: Healthcare, Biopharmaceutical, Biotechnology

Company Profile:

Inozyme Pharma is a Rare Disease Biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company estimated annual revenue is currently 7.4 million USD per year. The headquarters is in USA.

Company Website: INOZYME PHARMA, INC.